Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Stock Information for Palladyne AI Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Palladyne AI Corp.

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results
Eyenovia Provides Development Update on Optejet User Filled Device (UFD)
Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device
Eyenovia Announces 1-for-80 Reverse Stock Split
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote "FOR" Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders
Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.